4 months ago
AXSM
AnalystsSean LaamanSean Laaman's Stock Forecasts
AnalystsSean Laaman
Analyst Ranking
Top 25%
#1271 out of 5208 analysts
Average Return
+13.74%
Win Rate
64%14 out of 22
Risk vs Reward
Poor
Good
Sean Laaman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Resmed IncRMD | +90.17% | $134.65 | $256.07 | 2023-10-26 - 2024-10-25 | Strong Buy |
Beone Medicines LtdONC | +60.28% | $206.01 | $330.19 | 2024-12-02 - 2025-12-02 | Strong Buy |
Axsome Therapeutics IncAXSM | +58.91% | $105.44 | $167.55 | 2025-07-02 - 2026-01-08 | Strong Buy |
Halozyme Therapeutics IncHALO | +36.28% | $58.29 | $79.44 | 2025-02-13 - 2026-02-13 | Strong Buy |
Maplight Therapeutics IncMPLT | +28.73% | $13.99 | $18.01 | 2025-11-20 - 2026-03-03 | Strong Buy |
Sean Laaman Analyst Color
Get additional color on Sean Laaman's coverage of popular stocks
4 months ago
ONC
Sean Laaman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eikon Therapeutics IncEIKN | 1 | Strong Buy | $32.00 | +131.88% | Initiates Coverage On | 3 days ago |
Bridgebio Pharma IncBBIO | 2 | Strong Buy | $98.00 | +51.87% | Maintains | 8 days ago |
Exelixis IncEXEL | 6 | Hold | $49.00 | +20.27% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 4 | Hold | $204.00 | +24.35% | Downgrades | 2 months ago |
Certara IncCERT | 2 | Hold | $12.00 | +65.75% | Maintains | 3 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Strong Buy | $20.00 | +105.34% | Initiates Coverage On | 3 months ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $34.00 | +88.78% | Initiates Coverage On | 3 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $115.00 | +78.68% | Maintains | 4 months ago |
Resmed IncRMD | 2 | Strong Buy | $304.00 | +17.70% | Maintains | 4 months ago |
Beone Medicines LtdONC | 3 | Strong Buy | $383.00 | +28.94% | Maintains | 4 months ago |
Alector IncALEC | 1 | Strong Sell | $1.50 | -28.91% | Assumes | a year ago |
Halozyme Therapeutics IncHALO | 1 | Strong Buy | $67.00 | N/A | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.